Overview of Dr. Niravath
Dr. Polly Niravath is an oncologist in Houston, TX and is affiliated with multiple hospitals in the area, including Houston Methodist Hospital, Houston Methodist Sugar Land Hospital, Houston Methodist Willowbrook Hospital, Houston Methodist Baytown Hospital, Houston Methodist West Hospital, Houston Methodist The Woodlands Hospital, Houston Methodist Clear Lake Hospital, and St. Luke's Health - Baylor St. Luke's Medical Center. She received her medical degree from University of California, Irvine, School of Medicine and has been in practice 16 years. Dr. Niravath accepts several types of health insurance, listed below. She is one of 90 doctors at Houston Methodist Hospital and one of 97 doctors at St. Luke's Health - Baylor St. Luke's Medical Center who specialize in Oncology. She has more than 40 publications and over 500 citings.
Office
6445 Main St
# Opc
Houston, TX 77030Fax+1 713-441-8791
Education & Training
- Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
- Baylor College of MedicineResidency, Internal Medicine, 2005 - 2008
- University of California, Irvine, School of MedicineClass of 2005
Certifications & Licensure
- TX State Medical License 2007 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer Start of enrollment: 2007 Dec 01
- HKI-272 for HER2-Positive Breast Cancer and Brain Metastases
- Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer Start of enrollment: 2013 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsCharacterization of the Breast Cancer Liver Metastasis Microenvironment via Machine Learning Analysis of the Primary Tumor Microenvironment.Dylan A Goodin, Eric Chau, Junjun Zheng, Cailin O'Connell, Anjana Tiwari
Cancer Research Communications. 2024-10-01 - 11 citationsA Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.Kai Sun, Yitian Xu, Licheng Zhang, Polly Niravath, Jorge Darcourt
Clinical Cancer Research. 2022-10-14 - 2 citationsClinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases.Akshjot Puri, Charisma Mylavarapu, Jiaqiong Xu, Tejal A Patel, Bin S Teh
Breast Cancer Research and Treatment. 2022-06-01
Press Mentions
- The Eating and Drinking Habits That Affect Your Risk of Breast CancerOctober 11th, 2022
- The Eating and Drinking Habits That Affect Your Breast Cancer RiskOctober 11th, 2022
- Study Shows the Pain of Carrying Debt Can Be Physical, TooOctober 4th, 2021
- Join now to see all
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPOFirst Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: